Skip to content
Wenlo
Sign in
← Markets

Quest Diagnostics Incorporated

Quest Diagnostics Incorporated (DGX) — Form 144: Proposed sale of shares

144DGXFiled Nov 3, 2026, 10:10 AM ET

AI-generated summary

Officer Catherine T. Doherty proposed to sell 22,105 common shares of Quest Diagnostics Incorporated with an aggregate market value of $5,584,607.20 through Fidelity Brokerage Services LLC. The shares were acquired through a stock option exercise on November 3, 2026. The proposed sale is associated with a trading plan adopted on August 3, 2026.

Key facts

Seller
Doherty Catherine T.
Relationship
Officer
Shares to sell
22,105
Market value
$5,584,607.20
Approximate sale date
Nov 3, 2026
Broker
Fidelity Brokerage Services LLC
Acquired
Nov 3, 2026 · Stock Option Exercise

Rule 10b5-1 plan · adopted Aug 3, 2026

More DGX filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.